Now Available: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

GlobalData, the industry analysis specialist, has released its new report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France". The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of France. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of France. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

In 2012, france's population was approximately 65.3 million. The growth rate of the French population is decreasing steadily and this may be due to a negative balance between the mortality and birth rates, and low net rate of immigration. French policymakers are now presented with the problems of a Eurozone crisis, a declining population of the working age group and an increasing elderly population. The pharmaceutical market in France was estimated at $45.3 billion in 2012 and is expected to reach approximately $51 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 1.5%. The medical devices market size was approximately $14.7 billion in 2012 and is expected to reach approximately $20.8 billion by 2020 with a projected CAGR of 4.5%.

Full Report Details at
- http://www.fastmr.com/prod/608197_countryfocus_healthcare_regulatory_and.aspx?afid=301

The positive trends in the French healthcare market can be attributed primarily to -

* Increasing elderly population
* Universal healthcare insurance
* High degree of access to healthcare facilities

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of France. The scope includes -

* Overview of the pharmaceutical and medical devices market of France including the market size, market segmentation, key drivers and barriers.
* Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Sanofi, Novartis, F.Hoffmann-la Roche, GlaxoSmithKline, and AstraZeneca. The key players covered for the medical devices market are Siemens Healthcare, Hoffmann-La Roche, Medtronic, Essilor Internaltional and GlaxoSmithKline.
* Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices.
* A detailed analysis of the political and economic environment of France including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
* An overview of the opportunities and challenges for growth that exist in the healthcare market of France.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy
- Healthcare, Regulatory and Reimbursement Landscape - Germany
- Healthcare, Regulatory and Reimbursement Landscape - Spain
- Healthcare, Regulatory and Reimbursement Landscape - Japan
- Healthcare, Regulatory and Reimbursement Landscape Russia